Found 5 matching trials
Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma
PHASE1This study will be conducted in adult participants diagnosed with NSCLC who...
Location
Stanford University Medical Center
Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer
PHASE1This study will be conducted in adult participants diagnosed with any form ...
Location
Mayo Clinic Cancer Center - Scottsdale
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors
PHASE2This is a phase II trial of (RQ-07) in advanced solid tumors in prostate, b...
Location
Multiple Locations
Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer
PHASE1This phase Ib/II trial tests the safety and side effects of grapiprant and ...
Location
M D Anderson Cancer Center
A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers
PHASE1CJ-023,423 is a new medication being developed as an anti-inflammatory agen...
Location
Pfizer Investigational Site